All notes

INSIGHT

Jul 4, 2026

AI Confidence Theater Is Distorting Product Decisions at Scale

Projecting false certainty about AI outputs is becoming a structural problem in product teams. The pattern has a name now, and it deserves one.

There is a specific failure mode spreading through product and engineering orgs: teams ship AI features, encounter unpredictable outputs, and then paper over the uncertainty with confident framing in roadmaps, demos, and stakeholder updates. Elena Verna calls this AI confidence theater.

The core problem is not that AI systems are uncertain. That is expected and manageable. The problem is that the social dynamics around AI create pressure to perform certainty that does not exist. PMs under pressure to show AI progress overstate reliability. Engineers aware of edge cases stay quiet in demos. Executives repeat capability claims that engineering never actually validated.

This compounds. Once inflated claims enter a roadmap or a sales deck, correcting them requires admitting the original framing was wrong. Most organizations will not do that. So the theater continues until something breaks publicly or a product ships with behavior that surprises everyone except the engineers who built it.

For technical founders and senior engineers, the practical implication is straightforward: if your organization cannot talk honestly about AI failure modes internally, it cannot build reliable AI products. Confidence theater is not a communication problem. It is a signal that the feedback loop between engineering reality and product direction is broken.

The fix requires making uncertainty a first-class artifact. Eval results, known failure distributions, and confidence intervals belong in the same documents as feature specs and launch criteria. If a model behaves well on 80% of inputs and the remaining 20% are not characterized, that characterization is a prerequisite for shipping, not a post-launch task.

Solo founders have an advantage here. With no political layer between engineering and product, they can afford to be precise about what works and what does not. That precision is a competitive edge when the rest of the market is performing confidence they do not have.